Based on the cell surface expression of CD4 and CD8 molecules, murine thymocytes can be divided into four populations: these include CD4-, CD8-double-negative and CD4', CD8' double-positive subpopulations, both of which consist largely of immature cells, and the single positive, CD4' or CD8', subsets that contain functional helper or killer cells, respectively. The double-negative subset contains precursors of the other three populations and can reconstitute the thymus following intravenous or intrathymic transfer into irradiated hosts. In an attempt to establish the sequence of CD4 and CD8 expression during intrathymic development, we investigated the differentiation potential of highly purified CD8' thymocytes by using intravenous or intrathymic adoptive transfer. Unlike the double-negative thymocyte subset, CD8' cells did not have the ability to home to the thymus following intravenous transfer. However, when CD8' thymocytes were iniected directly into the thymus, they increased in number and gave rise to CD4+, CD8+ double-positive and CD4+ single-positive progeny. Furthermore, the rate of appearance of CD4+ cells from injected CD8+ precursors was faster than from the double-negative subset. Cells expressing a high surface density of CD8 convert to double-positive and CD4+ progeny without increasing in number, whereas CD8+ cells expressing a low surface density of the marker expand greatly and give rise to differentiated progeny. The results suggest that CD8 expression is an intermediate step on the differentiation pathway of mature CD4+ T cells.
CD8' thymocytes by using intravenous or intrathymic adoptive transfer. Unlike the double-negative thymocyte subset, CD8' cells did not have the ability to home to the thymus following intravenous transfer. However, when CD8' thymocytes were iniected directly into the thymus, they increased in number and gave rise to CD4+, CD8+ double-positive and CD4+ single-positive progeny. Furthermore, the rate of appearance of CD4+ cells from injected CD8+ precursors was faster than from the double-negative subset. Cells expressing a high surface density of CD8 convert to double-positive and CD4+ progeny without increasing in number, whereas CD8+ cells expressing a low surface density of the marker expand greatly and give rise to differentiated progeny. The results suggest that CD8 expression is an intermediate step on the differentiation pathway of mature CD4+ T cells.
The sequence of events occurring during T-cell maturation in the thymus is still poorly understood. T-cell precursors that first colonize the thymus during fetal development do not express CD4 or CD8 molecules on their surface (1, 2) . It has been proposed that these so-called "accessory" molecules may bind class II and class I major histocompatibility complex molecules, respectively; they are expressed on mutually exclusive subsets of mature T cells and their expression correlates with the restriction pattern of a given T cell (3) . The double-negative (DN) subset ofadult thymocytes contains the precursors of the other thymocyte subpopulations-namely, functionally immature ("cortical") CD4+8+ double-positive cells (DP) and the more mature single positive CD8+ and CD4+ cells (4) . Recent work from this laboratory has identified J11d+ cells as the source of precursors within the DN subset (5) and has indicated that interleukin 2 receptor (IL-2R) expression precedes further differentiation of DN cells (6) . The sequence of expression of CD4 and CD8 molecules during further development has not been clearly established. DP cells, which constitute the vast majority of thymocytes (>80%), may be the precursors of single-positive CD4+ and CD8+ thymocytes or they may be a dead-end stage. Indeed, these cells are known to have an extraordinarily high death rate (7) , and numerous attempts to show that they give rise to single-positive thymocytes have failed (reviewed in ref. 8 and our unpublished data).
CD8 expression can be detected before CD4 expression in fetal thymocyte ontogeny (9, 10) and following the intrathymic (i.t.) transfer of DN cells (6) . Because 4 antibody plus complement (which we refer to as CD4-simply to reflect their method ofisolation and not to imply that every low-density CD4+ cell has been removed) were positively selected for adherence to Petri dishes coated with anti-CD8 8634 Immunology: Nikolid-2ugid and Bevan antibody (18 (19) . Mice were anesthetized with tribromoethanol, the lower cervical area was exposed, and fascia and muscles were dislocated until the trachea was completely exposed. The In the experiment shown in Fig. 1 (Fig. 2 A and B) . In this experiment the CD8+ population expanded 3-fold by 8 days following transfer. In this and other experiments the DN population had a 2-to 10-fold greater proliferative potential than CD8+ thymocytes when assayed at 8-13 days.
Host-derived, Thy-1.1+ thymocytes were removed by antibody plus complement treatment and the surviving cells were analyzed for Thy-1.2 expression (Fig. 2 A and B) and for CD4 versus CD8 expression (Fig. 2 C and D) . Fig. 2D shows that the progeny of the i.t. injected CD8+ cells are mainly DP (73.3%) with a significant number of CD4+ cells (4.2%). The progeny of DN stem cells consist of far fewer CD4 singlepositive cells at this stage (Fig. 2C) . We are confident that the single-positive CD4+ cells in the thymus of the CD8+ recipients originate from the injected CD8+ cells because (i) irradiated, bone marrow reconstituted animals that did not receive an i.t. injection did not show this CD4+ population between days 7 and 12 after irradiation; (ii) the elimination of Thy-1.1+ cells from irradiated and bone marrow reconstituted animal spares <0.5% of thymic cells, and >90% of these do not stain with anti-CD8 or anti-CD4 antibodies; and (iii) unlike the case with humans (24) and rats (25) , murine macrophages do not express CD4 and are not stained by the reagent used in this study (26) . The thymuses that received an i.t. injection of CD8+ cells also contained a significantly higher number of bright-positive CD8' cells (Fig. 2D) (TS-FITC) fractionated the isolated CD8' population into CD8lo and CD8hi subsets on the FACS and injected the sorted populations i.t. The most striking difference between the two populations was in their i.t. proliferative potential. In several separate experiments the CD8hi cells did not increase in number, whereas the CD8lO cells expanded greatly in the thymus, as determined by FITC-anti-Thy-1.2 staining (Fig.  3) . In experiment 1 (Fig. 3A) the CD8lO cells increased 17-fold by day 9, and in experiment 2 (Fig. 3C) they increased 18-fold  by day 13 .
To analyze the differentiated progeny of the CD8IO and CD8hi cells, the thymus cells were treated with anti-Thy-1.1 antibody plus complement to eliminate host cells, and the surviving cells were analyzed for CD4 and CD8 expression (Fig. 4) . Anti-Thy-1.1 plus complement treatment of the hi CD8 recipient thymuses allowed 2.0% cell recovery, which is significantly higher than 0.3-0.5% recovery from irradiated, bone marrow protected mice that received no i.t.
injection. The surviving cells from the CD8`i injected animals showed 24.8% DP and 8.0% CD4' single-positive cells (Fig.  4A) . There was also a large percentage of CD8' bright cells in this population as well as DN and CD8-dull cells. Many or all of the CD8' bright cells may have had this mature phenotype at the time they were isolated from the donor thymus. Some of the DN cells in this population are certainly accounted for by host cells that survive the anti-Thy-1.1 treatment. Fig. 4B shows that although the progeny of the CD8lO cells have a greater proliferative potential than the CD8hi cells (Fig. 3) , they actually produce fewer CD4+ single-positive progeny by day 9. In this case the vast majority of the progeny are DP cells. However, by 13 days after i.t. injection, the CD8'°cells gave rise to significant numbers of CD4+ single-positive progeny (Fig. 4C) (Fig. 4) . In fact, the CD8hi cells throw off CD4 progeny earlier than the CD8lO cells. The CD8hi thymocytes that are able to differentiate in vivo are probably the subset of CD8' thymocytes that have been shown to be functionally immature and to express the Jild marker (27) and to lack surface expression of CD3 (28, 29 
